This company has been acquired
The company may no longer be operating, as it has been acquired. Find out why through their latest events.
De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
APEN Overzicht aandelen
Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices for gastrointestinal therapeutic endoscopy.
| Sneeuwvlok Score | |
|---|---|
| Waardering | 0/6 |
| Toekomstige groei | 2/6 |
| Prestaties in het verleden | 0/6 |
| Financiële gezondheid | 5/6 |
| Dividenden | 0/6 |
Apollo Endosurgery, Inc. Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | US$10.00 |
| 52 Week Hoogtepunt | US$10.30 |
| 52 Week Laag | US$3.49 |
| Bèta | 2.32 |
| 11 maand verandering | 0.50% |
| 3 maanden verandering | 1.11% |
| 1 Jaar Verandering | 67.79% |
| 33 jaar verandering | 360.83% |
| 5 jaar verandering | 70.94% |
| Verandering sinds IPO | -17.76% |
Recent nieuws en updates
Is Apollo Endosurgery (NASDAQ:APEN) Using Debt Sensibly?
Apr 03
Is Apollo Endosurgery (NASDAQ:APEN) Weighed On By Its Debt Load?
Nov 30Recent updates
Is Apollo Endosurgery (NASDAQ:APEN) Using Debt Sensibly?
Apr 03Is Apollo Endosurgery (NASDAQ:APEN) Weighed On By Its Debt Load?
Nov 30Is Apollo Endosurgery (NASDAQ:APEN) Using Too Much Debt?
Aug 05Apollo Endosurgery: Collect Shares At A Discount Following Q2 Earnings
Aug 04Is Apollo Endosurgery (NASDAQ:APEN) Using Debt Sensibly?
Mar 02Is Apollo Endosurgery, Inc. (NASDAQ:APEN) Trading At A 20% Discount?
Aug 04Apollo Endosurgery: New Management Bounce Makes Weight Loss Specialist A Buy
Jun 28Is Apollo Endosurgery (NASDAQ:APEN) A Risky Investment?
May 05Apollo Endosurgery EPS beats by $0.05, beats on revenue
May 04A Look At The Intrinsic Value Of Apollo Endosurgery, Inc. (NASDAQ:APEN)
Mar 24What Percentage Of Apollo Endosurgery, Inc. (NASDAQ:APEN) Shares Do Insiders Own?
Mar 03Trade Alert: Neil Gagnon At Apollo Endosurgery, Inc. (NASDAQ:APEN), Has Just Spent US$146k Buying 2.8% More Shares
Feb 10We Think Apollo Endosurgery (NASDAQ:APEN) Has A Fair Chunk Of Debt
Jan 31Assessing Apollo Endosurgery
Dec 27If You Had Bought Apollo Endosurgery's (NASDAQ:APEN) Shares Three Years Ago You Would Be Down 36%
Dec 27Is It Too Late To Consider Buying Apollo Endosurgery, Inc. (NASDAQ:APEN)?
Dec 01Apollo Endosurgery EPS beats by $0.10, beats on revenue
Nov 05Rendement voor aandeelhouders
| APEN | US Medical Equipment | US Markt | |
|---|---|---|---|
| 7D | 0.8% | 1.0% | 1.1% |
| 1Y | 67.8% | 26.6% | 32.2% |
Rendement versus industrie: APEN exceeded the US Medical Equipment industry which returned -13.3% over the past year.
Rendement versus markt: APEN exceeded the US Market which returned -11.4% over the past year.
Prijsvolatiliteit
| APEN volatility | |
|---|---|
| APEN Average Weekly Movement | 0.5% |
| Medical Equipment Industry Average Movement | 8.3% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 14.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stabiele aandelenkoers: APEN has not had significant price volatility in the past 3 months.
Volatiliteit in de loop van de tijd: APEN's weekly volatility has decreased from 12% to 1% over the past year.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 2005 | 202 | Chas McKhann | www.apolloendo.com |
Apollo Endosurgery, Inc. Samenvatting
| APEN fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | US$579.72m |
| Inkomsten(TTM) | -US$39.84m |
| Inkomsten(TTM) | US$76.86m |
7.5x
P/S-verhouding-14.6x
Koers/WinstverhoudingIs APEN overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| APEN resultatenrekening (TTM) | |
|---|---|
| Inkomsten | US$76.86m |
| Kosten van inkomsten | US$34.43m |
| Brutowinst | US$42.43m |
| Overige uitgaven | US$82.27m |
| Inkomsten | -US$39.84m |
Laatst gerapporteerde inkomsten
Dec 31, 2022
Volgende inkomensdatum
n.v.t.
| Winst per aandeel (EPS) | -0.69 |
| Brutomarge | 55.20% |
| Nettowinstmarge | -51.84% |
| Schuld/Eigen Vermogen Verhouding | 164.7% |
Hoe presteerde APEN op de lange termijn?
Bekijk historische prestaties en vergelijking